$209.17
-0.84-0.40%
At close: -
$209.25
0.080.04%
After Hours: 5:44 PM EDT
Comments
Loading...
AbbVie Earnings Estimates, EPS & Revenue | NYSE:ABBV | Benzinga
AbbVie reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 25
EPS Estimate
$2.600
Quarterly Revenue Estimate
$13.18B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$56.33B
Analyze the earnings history of AbbVie using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $2.31 | $2.60 | — | — | $12.31B | $13.18B | — | — | 04/25/2025 | Get Alert |
| ABBV | AbbVie | $2.79 | $2.26 | $2.16 | -4.42% | $14.30B | $14.83B | $15.10B | 1.83% | 01/31/2025 | Get Alert |
| ABBV | AbbVie | $2.95 | $2.92 | $3.00 | 2.74% | $13.93B | $14.28B | $14.46B | 1.26% | 10/30/2024 | Get Alert |
| ABBV | AbbVie | $2.91 | $2.57 | $2.65 | 3.11% | $13.87B | $14.03B | $14.46B | 3.08% | 07/25/2024 | Get Alert |
| ABBV | AbbVie | $2.46 | $2.23 | $2.31 | 3.59% | $12.22B | $11.92B | $12.31B | 3.27% | 04/26/2024 | Get Alert |
| ABBV | AbbVie | $3.60 | $2.77 | $2.79 | 0.72% | $15.12B | $14.02B | $14.30B | 2.00% | 02/02/2024 | Get Alert |
| ABBV | AbbVie | $3.66 | $2.86 | $2.95 | 3.15% | $14.81B | $13.70B | $13.93B | 1.66% | 10/27/2023 | Get Alert |
| ABBV | AbbVie | $3.37 | $2.80 | $2.91 | 3.93% | $14.58B | $13.52B | $13.87B | 2.55% | 07/27/2023 | Get Alert |
| ABBV | AbbVie | $3.16 | $2.46 | $2.46 | 0.00% | $13.54B | $12.17B | $12.22B | 0.45% | 04/27/2023 | Get Alert |
| ABBV | AbbVie | $3.08 | $3.56 | $3.60 | 1.12% | $14.89B | $15.31B | $15.12B | -1.23% | 02/09/2023 | Get Alert |
| ABBV | AbbVie | $2.83 | $3.59 | $3.66 | 1.95% | $14.34B | $14.96B | $14.81B | -0.99% | 10/28/2022 | Get Alert |
| ABBV | AbbVie | $3.11 | $3.33 | $3.37 | 1.20% | $13.96B | $14.62B | $14.58B | -0.25% | 07/29/2022 | Get Alert |
| ABBV | AbbVie | $2.95 | $3.14 | $3.16 | 0.64% | $13.01B | $13.63B | $13.54B | -0.67% | 04/29/2022 | Get Alert |
| ABBV | AbbVie | $2.92 | $3.28 | $3.31 | 0.91% | $13.86B | $14.98B | $14.89B | -0.63% | 02/02/2022 | Get Alert |
| ABBV | AbbVie | $2.83 | $3.22 | $3.33 | 3.42% | $12.90B | $14.32B | $14.34B | 0.15% | 10/29/2021 | Get Alert |
| ABBV | AbbVie | $2.34 | $3.09 | $3.11 | 0.65% | $10.43B | $13.63B | $13.96B | 2.41% | 07/30/2021 | Get Alert |
| ABBV | AbbVie | $2.42 | $2.83 | $2.95 | 4.24% | $8.62B | $12.76B | $13.01B | 1.96% | 04/30/2021 | Get Alert |
| ABBV | AbbVie | $2.21 | $2.85 | $2.92 | 2.46% | $8.70B | $13.70B | $13.86B | 1.15% | 02/03/2021 | Get Alert |
| ABBV | AbbVie | $2.33 | $2.76 | $2.83 | 2.54% | $8.48B | $12.72B | $12.90B | 1.43% | 10/30/2020 | Get Alert |
| ABBV | AbbVie | $2.26 | $2.19 | $2.34 | 6.85% | $8.26B | $10.08B | $10.43B | 3.42% | 07/31/2020 | Get Alert |
| ABBV | AbbVie | $2.14 | $2.25 | $2.42 | 7.56% | $7.83B | $8.33B | $8.62B | 3.47% | 05/01/2020 | Get Alert |
AbbVie (ABBV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-31 | $2.16 | $2.26 | -4.42 % |
| Q3 | 2024-10-30 | $3.00 | $2.92 | 2.74 % |
| Q2 | 2024-07-25 | $2.65 | $2.57 | 3.11 % |
| Q1 | 2024-04-26 | $2.31 | $2.23 | 3.59 % |
AbbVie (ABBV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-31 | $15.10B | $14.83B | 1.83 % |
| Q3 | 2024-10-30 | $14.46B | $14.28B | 1.26 % |
| Q2 | 2024-07-25 | $14.46B | $14.03B | 3.08 % |
| Q1 | 2024-04-26 | $12.31B | $11.92B | 3.27 % |
FAQ
When is AbbVie (NYSE:ABBV) reporting earnings?
AbbVie (ABBV) is scheduled to report earnings on April 25, 2025. The last reported earnings were for reported on January 31, 2025 for Q4.
What were the latest earnings per share (EPS) for AbbVie (NYSE:ABBV)?
The Actual EPS was $2.16, which missed the estimate of $2.26.
What were AbbVie’s (NYSE:ABBV) revenues?
The Actual Revenue was $15.1B, which beat the estimate of $14.8B.
Browse earnings estimates, EPS, and revenue on all stocks.